MedTrace Logo

Necrotizing Soft Tissue Infections

NCT07107555 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2025-08-06

No results posted yet for this study

Summary

SnapNSTI is an international, multicenter, time-bound prospective observational cohort study designed to characterize current epidemiology, management patterns, and outcomes of patients with necrotizing soft-tissue infections (NSTI). The primary objective is to estimate 90-day all-cause mortality and to evaluate the variability in management across centers. The study will also explore the association between clinical characteristics, treatments, and patient-reported outcomes.

Conditions

  • Necrotizing Soft Tissue Infection
  • Fournier Gangrene
  • Sepsis
  • Surgical Infection
  • Soft Tissue Infections

Sponsors & Collaborators

  • University of Pennsylvania

    collaborator OTHER

  • Hospital del Mar Research Institute (IMIM)

    collaborator OTHER

  • Hospital del Mar

    collaborator OTHER

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    collaborator OTHER

  • University of Birmingham

    collaborator OTHER

  • European Society for Trauma and Emergency Surgery

    lead OTHER

Principal Investigators

  • Gary A Bass, MD PhD · University of Pennsylvania

  • Ana Maria González Castillo, MD PhD · Hospital del Mar

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07107555 on ClinicalTrials.gov